| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/25/2005 | US20050186610 Tumor protein fusion for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 08/25/2005 | US20050186609 Using sequence variation in polymorphic fragment to determine sequence of single nucleotide polymorphism |
| 08/25/2005 | US20050186608 Therapeutic polypeptide recovered from mammalian milk for diagnosis, prevention and treatment of insulin resistance, cardiovascular and hypotensive disorders |
| 08/25/2005 | US20050186606 Reporter molecule fusion comprising interefering RNA for detection of preferential gene sequences |
| 08/25/2005 | US20050186604 Using histone acetyltransferase (HAT) inhibitor as therapeutic tool in treatment of cell proliferative disorders |
| 08/25/2005 | US20050186602 Using modified microarray to propagate preferential nucleotide sequences; polymerase chain recation |
| 08/25/2005 | US20050186601 Nucleic acid detection |
| 08/25/2005 | US20050186600 Polynucleotides encoding novel UbcH10 polypeptides and kits and methods using same |
| 08/25/2005 | US20050186598 Slide holder for use as support during scanning and/or screening of substrate comprising immobilized biopolymers |
| 08/25/2005 | US20050186597 Molecular dissection method using trans-splicing to designed spliced leader sequences, genes, and constructs thereof |
| 08/25/2005 | US20050186596 Methods for screening for proteins comprising a signal sequence |
| 08/25/2005 | US20050186595 Nucleic acid labeling method and liquid composition |
| 08/25/2005 | US20050186594 Antisense oligonucleotides for controlling G protein-coupled receptor kinase 6 and use in the treatment and prevention of rheumatoid arthritis, drug addiction, hypertension, reproductive and blood disorders |
| 08/25/2005 | US20050186591 Method of treating neurodegenerative disease |
| 08/25/2005 | US20050186590 Nucleic acid detection method having increased sensitivity |
| 08/25/2005 | US20050186589 Interspersed repetitive element RNAs as substrates, inhibitors and delivery vehicles for RNAi |
| 08/25/2005 | US20050186588 Designing primers for single step detection of biopolymer sequences |
| 08/25/2005 | US20050186587 Method for screening a substance which can suppress degradation of a nuclear receptor or a substance which can promote degradation of a nuclear receptor |
| 08/25/2005 | US20050186586 Methods and compositions for enhancing the efficacy and specificity of RNAi |
| 08/25/2005 | US20050186585 Multilayer apparatus for propagation of biopolymer sequences |
| 08/25/2005 | US20050186584 Mutant serine/threonine kinase for use as diagnostic indicator of cell proliferative disorders; antiproliferative agents; enzyme inhibitors |
| 08/25/2005 | US20050186582 Compositions and methods of using hexokinase V |
| 08/25/2005 | US20050186581 Computer-aided visualization and analysis system for sequence evaluation |
| 08/25/2005 | US20050186580 Matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS); contacting a polynucleotide bound to a substrate via a linker moiety having a triaryl methyl linker group with a matrix material; laser radiation cleaves linker |
| 08/25/2005 | US20050186579 MALDI-MS analysis of nucleic acids bound to a surface |
| 08/25/2005 | US20050186577 Using gene expression patterns in response to estrogen exposure as evaluative tool in determining recurrence of mammary gland cell proliferative disorders |
| 08/25/2005 | US20050186576 Polymer sequencing using selectively labeled monomers and data integration |
| 08/25/2005 | US20050186575 Corona-virus-like particles comprising functionally deleted genomes |
| 08/25/2005 | US20050186574 Anterior gradient 2 homolog (AGR2) for use as to in identifying modulator for treatment of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, vision defects, inflammatory bowel and cell proliferative disorders |
| 08/25/2005 | US20050186573 Polynucleotides for use as tags and tag complements in the detection of nucleic acid sequences |
| 08/25/2005 | US20050186572 Polymerase extension at 3' terminus of PNA-DNA chimera |
| 08/25/2005 | US20050186571 Diagnosis and prevention of cancer cell invasion |
| 08/25/2005 | US20050186570 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor |
| 08/25/2005 | US20050186569 Nucleic acid-associated proteins |
| 08/25/2005 | US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity |
| 08/25/2005 | US20050186566 Detection of modulator of defective cell proliferation; obtain cells with defects in cell proliferation, incubate with modulator, monitor adjustment in cell activity |
| 08/25/2005 | US20050186565 Using spectral-imaging device which utilizes surface plasmon resonance-modified multiband fluorescence polarization and polarized phase shifting of reflected light to screen pharmaceuticals, detect chemical warfare agents and verify microorganismal infection |
| 08/25/2005 | US20050186561 Using concentration of macroglobulins, hyaluronic acid (HA) and/or tissue inhibitor of metalloproteinases-1 (TIMP-1) as diagnostic indicators of viral and liver disorders |
| 08/25/2005 | US20050186560 Mammalian cell expressing viral replication protein for use as tool in identifying modulators for treatment of cell proliferative and autoimmune disorders; immunotherapy |
| 08/25/2005 | US20050186559 Identifying Amyloid precurser protein lowering agents; non-steroidal anti-inflammatory drug (NSAID); Alzheimer's disease |
| 08/25/2005 | US20050186557 Cytotoxicity assay |
| 08/25/2005 | US20050186556 Kit comprising cell migration apparatus which improves identification and distinction of chemokine receptor antagonists from non-specific blockers |
| 08/25/2005 | US20050186555 Naphthofluorescein-based metal sensors, and methods of making and using the same |
| 08/25/2005 | US20050186554 Image analysis and assay system |
| 08/25/2005 | US20050186333 Strip electrode with conductive nano tube printing |
| 08/25/2005 | US20050186266 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/25/2005 | US20050186233 Administration of agents mimicking dopachrome tautomerase (TRP-2) activity for protecting hair follicle melanocytes |
| 08/25/2005 | US20050186226 treating diseases such as HIV/AIDS disease, oncological ailments, tuberculosis, rheumatics, etc. by autohaemovaccinoimmunotherapy |
| 08/25/2005 | US20050186215 CUDR as biomarker for cancer progression and therapeutic response |
| 08/25/2005 | US20050186211 Use of mda-5 as an antiviral and antiproliferative agent |
| 08/25/2005 | US20050186200 HADHs as modifiers of the p21 pathway and methods of use |
| 08/25/2005 | US20050183965 Sensor is a carbon working electrode and a ferrocyanide redox mediator; analyte is glucose; interfering compound current results from oxidation of acetaminophen, ascorbic acid, bilirubin, dopamine, gentisic acid, glutathione, levodopa, methyldopa, tolazimide, tolbutamide, uric acid |
| 08/25/2005 | US20050183494 Device having a flow channel containing a layer of wicking material |
| 08/25/2005 | DE19903920B4 Sebozyten, Sebozyten-Zellinie und deren Verwendungen Sebocytes, sebocytes cell line and their uses |
| 08/25/2005 | DE102005003911A1 Transducer assembly to measure the concentration and changes in a redox active substance, as a mediator in a molecular biological detection system, uses a pulsed potential at an electrode to give measurement and relaxation phases |
| 08/25/2005 | DE102004006477A1 Process for demonstrating the presence of single nucleotide polymorphism in human genes, comprises using a priming agent |
| 08/25/2005 | CA2601952A1 Probe for detecting nuclear receptor agonist or antagonist and method for screening agonist or antagonist to nuclear receptor using the same |
| 08/25/2005 | CA2597127A1 Mutation associated with lacunar strokes |
| 08/25/2005 | CA2559359A1 Identification of snps associated with hyperlipidemia, dyslipidemia and defective carbohydrate metabolism |
| 08/25/2005 | CA2559134A1 Target genes for inflammatory bowel disease |
| 08/25/2005 | CA2558879A1 Regulatory cell controlling immunological activity of t cell |
| 08/25/2005 | CA2558662A1 Method of detecting and identifying gram-negative obligative anaerobic bacterium |
| 08/25/2005 | CA2556611A1 Cpg-amplicon and array protocol |
| 08/25/2005 | CA2556219A1 Methods for assaying cells using cell-substrate impedance monitoring |
| 08/25/2005 | CA2556111A1 Method for detecting the risk of cancer, coronary heart disease, and stroke by analysing a catalase gene |
| 08/25/2005 | CA2555866A1 Diagnostic markers for cancer |
| 08/25/2005 | CA2555848A1 Antibody targeting osteoclast-associated protein |
| 08/25/2005 | CA2555835A1 Method of detecting and identifying lactic acid bacterium |
| 08/25/2005 | CA2555704A1 Method for detection of promoter methylation status |
| 08/25/2005 | CA2555657A1 Tb resistance assay |
| 08/25/2005 | CA2555580A1 Analyte sensor, and associated system and method employing a catalytic agent |
| 08/25/2005 | CA2555531A1 Methods and compositions for combination rnai therapeutics |
| 08/25/2005 | CA2555324A1 Gene profiling of human embryonic stem cells |
| 08/25/2005 | CA2555145A1 Diagnosis and therapeutics for cancer |
| 08/25/2005 | CA2555142A1 Cell proliferation associated with ccx ckr expression |
| 08/25/2005 | CA2555140A1 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 08/25/2005 | CA2555138A1 Method for determining reduced susceptibility of hiv to protease inhibitor treatment |
| 08/25/2005 | CA2555132A1 Compounds that inhibit hiv particle formation |
| 08/25/2005 | CA2555017A1 Method and kit for identifying function of gene product and identifying binding substance |
| 08/25/2005 | CA2554971A1 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 08/25/2005 | CA2554818A1 Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features |
| 08/25/2005 | CA2554664A1 Complexed polypeptide and adjuvant for improved vaccines |
| 08/25/2005 | CA2554575A1 Preparation of biologically derived fluids for biomarker determination by mass spectrometry |
| 08/25/2005 | CA2554534A1 Process for large scale production of plasmid dna by e. coli fermentation |
| 08/25/2005 | CA2554380A1 Mecp2e1 gene |
| 08/25/2005 | CA2553632A1 Oxidizable species as an internal reference for biosensors and method of use |
| 08/25/2005 | CA2550429A1 Method of prognosis of metastasis by detection of fra12e fragile site within the smrt gene/locus at chromosome 12q24 |
| 08/25/2005 | CA2550401A1 Method and compositions for detecting botulinum neurotoxin |
| 08/25/2005 | CA2536325A1 Transient production of pharmaceutically important proteins in plants |
| 08/24/2005 | EP1566760A2 Method and system of replacing missing genotyping data |
| 08/24/2005 | EP1566638A1 Method of fixing biomolecule on metal support |
| 08/24/2005 | EP1566637A1 Single layer teststrip |
| 08/24/2005 | EP1566635A1 Microwell array chip for detecting antigen-specific lymphocyte, method of detecting antigen-specific lymphocyte and method of cloning antigen-specific lymphocyte antigen receptor gene |
| 08/24/2005 | EP1566453A2 Qualitative differential splicing |
| 08/24/2005 | EP1566452A2 Gene information display method and apparatus |
| 08/24/2005 | EP1566451A2 Detection reagent for Shiga toxin family gene of entero-hemorrhagic Escherichia coli |
| 08/24/2005 | EP1566450A2 Reagent and method for detecting the gene 17.5 linked to the MHC of breeding birds |
| 08/24/2005 | EP1566449A1 Use of haplotypes and SNPs in lipid-relevant genes for the analyses and diagnosis of cardiovascular diseases |
| 08/24/2005 | EP1566448A2 Differential diagnosis with Hepcidine |
| 08/24/2005 | EP1566447A1 Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase C regulation |